200 related articles for article (PubMed ID: 19945458)
21. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
Crocker PR
Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
[TBL] [Abstract][Full Text] [Related]
22. High-affinity ligands of Siglec receptors and their therapeutic potentials.
Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
[TBL] [Abstract][Full Text] [Related]
23. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
24. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides.
Avril T; Wagner ER; Willison HJ; Crocker PR
Infect Immun; 2006 Jul; 74(7):4133-41. PubMed ID: 16790787
[TBL] [Abstract][Full Text] [Related]
25. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation.
Büll C; Collado-Camps E; Kers-Rebel ED; Heise T; Søndergaard JN; den Brok MH; Schulte BM; Boltje TJ; Adema GJ
Immunol Cell Biol; 2017 Apr; 95(4):408-415. PubMed ID: 27874015
[TBL] [Abstract][Full Text] [Related]
26. Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.
Khatua B; Roy S; Mandal C
Indian J Med Res; 2013 Nov; 138(5):648-62. PubMed ID: 24434319
[TBL] [Abstract][Full Text] [Related]
27. Siglec-5 is an inhibitory immune checkpoint molecule for human T cells.
Vuchkovska A; Glanville DG; Scurti GM; Nishimura MI; White P; Ulijasz AT; Iwashima M
Immunology; 2022 Jun; 166(2):238-248. PubMed ID: 35290663
[TBL] [Abstract][Full Text] [Related]
28. Sialylation of outer membrane porin protein D: a mechanistic basis of antibiotic uptake in Pseudomonas aeruginosa.
Khatua B; Van Vleet J; Choudhury BP; Chaudhry R; Mandal C
Mol Cell Proteomics; 2014 Jun; 13(6):1412-28. PubMed ID: 24643970
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
[TBL] [Abstract][Full Text] [Related]
30. A Sulfonamide Sialoside Analogue for Targeting Siglec-8 and -F on Immune Cells.
Nycholat CM; Duan S; Knuplez E; Worth C; Elich M; Yao A; O'Sullivan J; McBride R; Wei Y; Fernandes SM; Zhu Z; Schnaar RL; Bochner BS; Paulson JC
J Am Chem Soc; 2019 Sep; 141(36):14032-14037. PubMed ID: 31460762
[TBL] [Abstract][Full Text] [Related]
31. A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands.
Rodrigues E; Jung J; Park H; Loo C; Soukhtehzari S; Kitova EN; Mozaneh F; Daskhan G; Schmidt EN; Aghanya V; Sarkar S; Streith L; St Laurent CD; Nguyen L; Julien JP; West LJ; Williams KC; Klassen JS; Macauley MS
Nat Commun; 2020 Oct; 11(1):5091. PubMed ID: 33037195
[TBL] [Abstract][Full Text] [Related]
32. Discovery of a new sialic acid binding region that regulates Siglec-7.
Yamakawa N; Yasuda Y; Yoshimura A; Goshima A; Crocker PR; Vergoten G; Nishiura Y; Takahashi T; Hanashima S; Matsumoto K; Yamaguchi Y; Tanaka H; Kitajima K; Sato C
Sci Rep; 2020 May; 10(1):8647. PubMed ID: 32457377
[TBL] [Abstract][Full Text] [Related]
33. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
Razi N; Varki A
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
[TBL] [Abstract][Full Text] [Related]
34. Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.
Benmerzoug S; Chevalier MF; Verardo M; Nguyen S; Cesson V; Schneider AK; Dartiguenave F; Rodrigues-Dias SC; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
Eur Urol Focus; 2022 May; 8(3):748-751. PubMed ID: 34147404
[TBL] [Abstract][Full Text] [Related]
35. Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells.
Yoshimura A; Asahina Y; Chang LY; Angata T; Tanaka H; Kitajima K; Sato C
J Biol Chem; 2021; 296():100477. PubMed ID: 33640457
[TBL] [Abstract][Full Text] [Related]
36. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
Carlin AF; Uchiyama S; Chang YC; Lewis AL; Nizet V; Varki A
Blood; 2009 Apr; 113(14):3333-6. PubMed ID: 19196661
[TBL] [Abstract][Full Text] [Related]
37. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein.
Blixt O; Collins BE; van den Nieuwenhof IM; Crocker PR; Paulson JC
J Biol Chem; 2003 Aug; 278(33):31007-19. PubMed ID: 12773526
[TBL] [Abstract][Full Text] [Related]
38. Ganglioside binding pattern of CD33-related siglecs.
Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
[TBL] [Abstract][Full Text] [Related]
39. Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein.
Nordström T; Movert E; Olin AI; Ali SR; Nizet V; Varki A; Areschoug T
J Biol Chem; 2011 Sep; 286(39):33981-91. PubMed ID: 21795693
[TBL] [Abstract][Full Text] [Related]
40. Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
Meril S; Harush O; Reboh Y; Matikhina T; Barliya T; Cohen CJ
Mol Carcinog; 2020 Jul; 59(7):713-723. PubMed ID: 32391973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
